跳至主要内容
临床试验/NCT01651013
NCT01651013进行中(未招募)不适用

Multicentered Observational Prospective Cohort Study on the Treatment of Metastatic Colorectal Cancer and the Role of Evaluating K-Ras

National Cancer Institute, Naples4 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
500
试验地点
4
主要终点
Percentage of patients with K-Ras mutation

研究概览

简要总结

The purpose of this study is to describe the treatments received and outcomes of patients with metastatic colorectal cancer, what percentage of these patients have K-Ras mutation of the tumor, and to describe the costs of treatments. Information will also be collected regarding risk factors, variables among treatment centers and patients, and explorative analyses will be done to try to identify factors that impact prognosis and factors that predict tolerability and response to treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologic diagnosis colorectal carcinoma
  • Metastatic disease
  • Signed informed consent

排除标准

  • Prior treatment of metastatic colorectal cancer
  • Refusal or incapability of providing informed consent

结局指标

主要结局

Percentage of patients with K-Ras mutation

时间窗: 2 years

percentage of patients enrolled in a clinical trial

时间窗: two years

percentage of patients who undergo K-Ras mutation study

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
National Cancer Institute, Naples
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验